The estrogen blockers market size is expected to see significant growth in the coming years. From a robust valuation of $8.72 billion in 2023, the market is projected to reach $9.35 billion in 2024, ...

Testosterone blockers, also known as anti-androgen drugs, are commonly prescribed to transgender women to block the effects of testosterone, the primary male sex hormone. By doing so, the drug can ...